Clinical Impact of the Line Probe Assay and Xpert® MTB/RIF Assay in the Presumptive Diagnosis of Drug-Resistant Tuberculosis in Brazil: A Pragmatic Clinical Trial-Reference-Cited by-同舟云学术

Clinical Impact of the Line Probe Assay and Xpert® MTB/RIF Assay in the Presumptive Diagnosis of Drug-Resistant Tuberculosis in Brazil: A Pragmatic Clinical Trial

Published:2022 Issue: Volume:55 Page:
ISSN:1678-9849
Container-title:Revista da Sociedade Brasileira de Medicina Tropical
language:
Short-container-title:Rev. Soc. Bras. Med. Trop.

Author:

Kritski Afranio¹^ORCID,Oliveira Maria Martha¹^ORCID,Almeida Isabela Neves de²^ORCID,Ramalho Daniela¹^ORCID,Andrade Monica Kramer de Noronha³^ORCID,Carvalho Monica⁴^ORCID,Miranda Pryscila Fernandes Campino¹^ORCID,Dalcolmo Margareth Pretti⁴^ORCID,Braga Jose Ueleres⁵^ORCID,Brígido Tania⁶,Mesquita Eliene⁷^ORCID,Dias Claudia⁸^ORCID,Gambirasio Aglae⁹^ORCID,Souza Filho Joao Baptista¹^ORCID,Detjen Anne¹⁰^ORCID,Phillips Patrick Peter John¹¹^ORCID,Langley Ivor¹²^ORCID,Fujiwara Paula¹³^ORCID,Squire Stephen Bertel¹²^ORCID

Affiliation:

1. Universidade Federal do Rio de Janeiro, Brasil

2. Universidade Federal de Ouro Preto, Brasil

3. Universidade Federal do Rio de Janeiro, Brasil; Fundação Oswaldo Cruz, Brasil

4. Fundação Oswaldo Cruz, Brasil

5. Universidade do Estado do Rio de Janeiro, Brasil

6. Secretaria da Saúde do Ceará, Brasil

7. Secretaria de Estado de Saúde do Rio de Janeiro, Brasil

8. Secretaria de Estado de Saúde do Rio Grande do Sul, Brasil

9. Secretaria de Estado da Saúde de São Paulo, Brasil

10. United Nations Children’s Fund, USA

11. Institute of Clinical Trials and Methodology, United Kingdom; University of California, USA

12. Liverpool School of Tropical Medicine, United Kingdom

13. University of California, USA

Publisher

FapUNIFESP (SciELO)

Subject

Infectious Diseases,Microbiology (medical),Parasitology

Reference28 articles.

1. Global Tuberculosis Report 2020,2020

2. Use of liquid TB culture and drug susceptibility testing (DST) in low and medium income settings. Summary report of the expert group meeting on the use of liquid culture media,2007

3. Moving research findings into new WHO policies,2008

4. Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?;Albert H;Eur Respir J,2016

5. Global strategy and targets for tuberculosis prevention, care and control after 2015,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The performance of Xpert MTB/RIF and MTBDRplus within a Programmatic setting at TB Laboratory in Rio de Janeiro, Brazil;Revista da Sociedade Brasileira de Medicina Tropical;2024

2. The Role of GeneXpert® for Tuberculosis Diagnostics in Brazil: An Examination from a Historical and Epidemiological Perspective;Tropical Medicine and Infectious Disease;2023-10-26

3. Estimating the effect of a rifampicin resistant tuberculosis diagnosis by the Xpert MTB/RIF assay on two-year mortality;PLOS Global Public Health;2023-09-01

4. MTBDRplus and MTBDRsl for simultaneous diagnosis of gastrointestinal tuberculosis and detection of first‐line and second‐line drug resistance;Journal of Gastroenterology and Hepatology;2023-01-30